Cancers | Free Full-Text | TLD1433 Photosensitizer Inhibits Conjunctival Melanoma Cells in Zebrafish Ectopic and Orthotopic Tumour Models
Clinical Development of Metal Complexes as Photosensitizers for Photodynamic Therapy of Cancer - Karges - 2022 - Angewandte Chemie International Edition - Wiley Online Library
Theralase Technologies Inc shares rocket on TLD-1433 clinical trial findings
Theralase Research Published in International Peer-Reviewed Journal – Theralase Technologies
Ruthenium complexes that have been tested in phase I clinical trials. | Download Scientific Diagram
Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433 | Chemical Reviews
Medicinal inorganic chemistry: an updated review on the status of metallodrugs and prominent metallodrug candidates
Theralase Technologies Inc seeks OK from Health Canada to start hase Ib clinical trial for the treatment of non-muscle invasive bladder cancer
Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433. - Abstract - Europe PMC
McFarland Research Group | UNCG
Photo Dynamic Therapy | Theralase Technologies Inc. – Theralase Technologies
Anticancer Photodynamic Therapy Using Ruthenium(II) and Os(II)-Based Complexes as Photosensitizers | IntechOpen
In vitro dose‐response curves to determine the LD50 for T24 cells (A,C)... | Download Scientific Diagram
Cancers | Free Full-Text | TLD1433 Photosensitizer Inhibits Conjunctival Melanoma Cells in Zebrafish Ectopic and Orthotopic Tumour Models
Anticancer Ru complexes in clinical trials. | Download Scientific Diagram
Non-Muscle Invasive Bladder Cancer Pipeline Insights
NAMI-A and KP1019/NKP1339 are ruthenium complexes that entered clinical... | Download Scientific Diagram
Clinical development and potential of photothermal and photodynamic therapies for cancer | Nature Reviews Clinical Oncology
Metal-based photosensitizers for photodynamic therapy: the future of multimodal oncology? - ScienceDirect
Green light irradiation of TLD1433 induces apoptosis and necrosis in... | Download Scientific Diagram
CUOS 2019: Photodynamic Therapy for Bladder Cancer: Results of a Phase Ib Clinical Trial
Minimal required PDT light dosimetry for nonmuscle invasive bladder cancer
Cancers | Free Full-Text | TLD1433 Photosensitizer Inhibits Conjunctival Melanoma Cells in Zebrafish Ectopic and Orthotopic Tumour Models
